CWM
MDGL icon

CIBC World Markets’s Madrigal Pharmaceuticals MDGL Stock Holding History

CIBC World Markets’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$717K Buy
+1,231
New +$629K ﹤0.01% 781
2025
Q2 		$629K Sell
2,080
-1,909
-48% -$569K ﹤0.01% 780
2025
Q1 		$1.32M Buy
3,989
+2,308
+137% +$758K 0.01% 604
2024
Q4 		$519K Buy
+1,681
New +$473K ﹤0.01% 726

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CIBC World Markets's MDGL Position: Q4 2025 in Review

CIBC World Markets opened a new position in Madrigal Pharmaceuticals (MDGL) in Q4 2025: 1,231 shares worth $717K. The stake represents ﹤0.01% of the portfolio and ranks #781 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in MDGL as recently as Q2 2025.

CIBC World Markets first reported a position in MDGL in Q4 2024 and has held it in 4 quarters since. The position peaked at $1.32M in Q1 2025. 387 funds tracked by Wall St. Rank hold MDGL as of Q4 2025.

  • CIBC World Markets held 1,231 shares of Madrigal Pharmaceuticals worth $717K as of Q4 2025.
  • Madrigal Pharmaceuticals was a new CIBC World Markets position in Q4 2025.
  • Madrigal Pharmaceuticals made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #781 holding.
  • CIBC World Markets first reported a position in Madrigal Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • CIBC World Markets's Madrigal Pharmaceuticals position peaked at $1.32M in Q1 2025.
  • 387 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.